Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Hits New 12-Month Low at $51.60

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTFGet Free Report) hit a new 52-week low on Thursday . The company traded as low as $51.60 and last traded at $51.60, with a volume of 0 shares traded. The stock had previously closed at $51.60.

Recordati Industria Chimica e Farmaceutica Price Performance

The business’s fifty day moving average is $51.60 and its two-hundred day moving average is $48.41. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.28 and a quick ratio of 0.86.

About Recordati Industria Chimica e Farmaceutica

(Get Free Report)

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.

Featured Stories

Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.